Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer
- 25 March 2023
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 128 (11) , 2025-2035
Abstract
Background Histopathologic regression following neoadjuvant treatment (NT) of oesophageal cancer is a prognostic factor of survival, but the nodal status is not considered. Here, a score combining both to improve prediction of survival after neoadjuvant therapy is developed. Methods Seven hundred and fifteen patients with oesophageal squamous cell (SCC) or adenocarcinoma (AC) undergoing NT and esophagectomy were analysed. Histopathologic response was classified according to percentage of vital residual tumour cells (VRTC): complete response (CR) without VRTC, major response with 10% VRTC. Nodal stage was classified as ypN0 and ypN+. Kaplan–Meier and Cox regression were used for survival analysis. Results Survival analysis identified three groups with significantly different mortality risks: (1) low-risk group for CR (ypT0N0) with 72% 5-year overall survival (5y-OS), (2) intermediate-risk group for minor/major responders and ypN0 with 59% 5y-OS, and (3) high-risk group for minor/major responders and ypN+ with 20% 5y-OS (p < 0.001). Median survival in AC and SCC cohorts were comparable (3.8 (CI 95%: 3.1, 5.3) vs. 4.6 years (CI 95%: 3.3, not reached), p = 0.3). Conclusions Histopathologic regression and nodal status should be combined for estimating AC and SCC prognosis. Poor survival in the high-risk group highlights need for adjuvant therapy.Keywords
This publication has 43 references indexed in Scilit:
- Reply to LetterAnnals of Surgery, 2014
- Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS TrialsJournal of Clinical Oncology, 2014
- A Multifactorial Histopathologic Score for the Prediction of Prognosis of Resected Esophageal Adenocarcinomas After Neoadjuvant ChemotherapyAnnals of Surgical Oncology, 2013
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- A Multicenter Study of Survival After Neoadjuvant Radiotherapy/Chemotherapy and Esophagectomy for ypT0N0M0R0 Esophageal CancerAnnals of Surgery, 2010
- Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal CancerAnnals of Surgical Oncology, 2010
- Ivor‐Lewis Esophagectomy With and Without Laparoscopic Conditioning of the Gastric ConduitWorld Journal of Surgery, 2010
- Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal CancerAnnals of Surgery, 2005
- Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapyCancer, 2003
- Japanese Classification of Gastric Carcinoma – 2nd English Edition –Gastric Cancer, 1998